Genpact Limited
US ˙ NYSE ˙ BMG3922B1072

Introduction

This page provides a comprehensive analysis of the known insider trading history of Alex Mandl. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Alex Mandl has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:RCM / R1 RCM Inc. Director 93,871
US:G / Genpact Limited Director 39,911
Director 0
US:US3623933088 / GTT COMMUNICATIONS INC Director 16,129
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Alex Mandl. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases G / Genpact Limited - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in G / Genpact Limited. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

G / Genpact Limited Insider Trades
Insider Sales G / Genpact Limited - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in G / Genpact Limited. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

G / Genpact Limited Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Alex Mandl as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-11-19 2021-11-18 4 RCM R1 RCM INC.
Common Stock
S - Sale -140,829 93,871 -60.00 25.40 -3,577,197 2,384,417
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
M - Exercise -6,472 9,592 -40.29
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
M - Exercise -16,168 0 -100.00
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Common Stock
S - Sale -34,171 234,700 -12.71 25.60 -874,641 6,007,381
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Common Stock
M - Exercise 6,472 47,234 15.88 2.53 16,374 119,502
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Common Stock
M - Exercise 12,500 40,762 44.23 3.20 40,000 130,438
2021-11-19 2021-11-17 4 RCM R1 RCM INC.
Common Stock
M - Exercise 16,168 28,262 133.69 2.50 40,420 70,655
2021-10-13 2021-10-12 4 RCM R1 RCM INC.
Common Stock
G - Gift -268,871 12,094 -95.70
2021-05-28 2021-05-28 4 RCM R1 RCM INC.
Restricted Stock Units
M - Exercise -12,094 5,151 -70.13
2021-05-28 2021-05-28 4 RCM R1 RCM INC.
Common Stock
M - Exercise 12,094 280,965 4.50
2021-05-24 2021-05-21 4 RCM R1 RCM INC.
Restricted Stock Units
A - Award 5,151 17,245 42.59
2020-10-02 2020-10-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 3,643 3,643 6.86 25,002 25,002
2020-07-02 2020-07-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 5,414 5,414 4.62 25,002 25,002
2020-06-15 2020-06-14 4 RCM R1 RCM INC.
Restricted Stock Units
M - Exercise -11,207 12,094 -48.10
2020-06-15 2020-06-14 4 RCM R1 RCM INC.
Common Stock
M - Exercise 11,207 268,871 4.35
2020-05-29 2020-05-28 4 RCM R1 RCM INC.
Restricted Stock Units
A - Award 12,094 23,301 107.91
2020-04-03 2020-04-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 7,569 7,569 3.30 25,000 25,000
2020-01-03 2020-01-02 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 4,751 4,751 5.26 24,990 24,990
2019-10-03 2019-10-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 6,708 6,708 3.73 25,021 25,021
2019-07-02 2019-07-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 4,743 4,743 5.27 24,996 24,996
2019-06-18 2019-06-14 4 RCM R1 RCM INC.
Restricted Stock Units
A - Award 11,207 11,207
2019-06-04 2019-05-31 4 RCM R1 RCM INC.
Restricted Stock Units
M - Exercise -16,394 0 -100.00
2019-06-04 2019-05-31 4 RCM R1 RCM INC.
Common Stock
M - Exercise 16,394 257,664 6.79
2019-04-02 2019-04-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 6,140 6,140 4.07 24,990 24,990
2019-01-03 2019-01-02 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 7,141 7,141 3.50 24,994 24,994
2018-12-20 2018-12-18 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 2,756 2,756 3.63 10,004 10,004
2018-10-03 2018-10-01 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 4,425 4,425 4.52 20,001 20,001
2018-09-18 2018-09-14 4 RCM R1 RCM INC.
Restricted Stock Units
M - Exercise -41,270 0 -100.00
2018-09-18 2018-09-14 4 RCM R1 RCM INC.
Common Stock
M - Exercise 41,270 241,270 20.64
2018-07-03 2018-07-02 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 5,162 5,162 3.88 20,003 20,003
2018-05-31 2018-05-31 4 RCM R1 RCM INC.
Restricted Stock Units
A - Award 16,394 16,394
2018-05-10 2018-05-08 4 G Genpact LTD
Common Shares
A - Award 3,961 39,911 11.02
2018-04-03 2018-04-02 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 6,360 6,360 3.14 20,002 20,002
2018-01-03 2018-01-02 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 10,262 10,262 1.95 20,011 20,011
2017-10-03 2017-10-02 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 12,225 12,225 1.64 20,049 20,049
2017-09-18 2017-09-14 4 RCM R1 RCM INC.
Restricted Stock Units
A - Award 41,270 41,270
2017-07-05 2017-07-03 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 12,904 12,904 1.55 20,001 20,001
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 72,256 72,256
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -5,496 0 -100.00
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -5,324 0 -100.00
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -4,598 0 -100.00
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -3,793 0 -100.00
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -3,743 0 -100.00
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -3,559 0 -100.00
2017-06-13 2017-06-12 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
D - Sale to Issuer -109,473 0 -100.00
2017-05-11 2017-05-09 4 G Genpact LTD
Common Shares
A - Award 4,700 35,950 15.04
2017-04-05 2017-04-03 4 RCM R1 RCM INC.
Director Stock Option (right to buy)
A - Award 14,016 14,016 1.43 20,001 20,001
2017-01-04 2017-01-03 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 18,797 18,797 1.06 20,000 20,000
2016-10-05 2016-10-03 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 18,349 18,349 1.09 20,000 20,000
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 20,000 200,000 11.11 1.55 31,000 310,000
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 1,000 180,000 0.56 1.54 1,540 277,200
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 5,000 179,000 2.87 1.53 7,650 273,870
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 25,001 174,000 16.78 1.80 45,002 313,200
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 5,599 148,999 3.90 1.79 10,022 266,708
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 4,500 143,400 3.24 1.51 6,795 216,534
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 1,300 138,900 0.94 1.76 2,288 244,464
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 2,500 137,600 1.85 1.74 4,350 239,424
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 10,100 135,100 8.08 1.73 17,473 233,723
2016-08-11 2016-08-11 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 10,000 125,000 8.70 1.72 17,200 215,000
2016-08-11 2016-08-10 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 13,100 115,000 12.86 1.53 20,043 175,950
2016-08-11 2016-08-10 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 1,200 101,900 1.19 1.51 1,812 153,869
2016-08-11 2016-08-10 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 35,000 100,700 53.27 1.51 52,850 152,057
2016-08-11 2016-08-10 4 ACHI Accretive Health, Inc.
Common Stock
P - Purchase 65,700 65,700 1.51 99,207 99,207
2016-07-06 2016-07-01 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 20,513 20,513 0.98 20,000 20,000
2016-05-04 2016-05-02 4 G Genpact LTD
Common Shares
A - Award 4,270 31,250 15.83
2016-04-05 2016-04-01 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 16,064 16,064 1.24 20,000 20,000
2016-01-06 2016-01-04 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 12,500 12,500 1.60 20,000 20,000
2015-10-05 2015-10-01 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 16,168 16,168 1.24 20,000 20,000
2015-07-06 2015-07-01 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 5,496 5,496 2.73 14,999 14,999
2015-05-15 2015-05-13 4 G Genpact LTD
Common Shares
A - Award 5,224 26,980 24.01
2015-04-02 2015-04-01 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 5,324 5,324 2.82 15,014 15,014
2015-01-06 2015-01-02 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 4,598 4,598 3.26 14,989 14,989
2014-10-02 2014-10-01 4 ACHI Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 3,793 3,793 3.95 14,982 14,982
2014-07-02 2014-07-01 4 AH Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 3,743 3,743 4.01 15,009 15,009
2014-05-08 2014-05-07 4 G Genpact LTD
Common Shares
A - Award 7,285 21,756 50.34
2014-04-03 2014-04-01 4 AH Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 3,559 3,559 4.21 14,983 14,983
2014-01-08 2014-01-07 4 AH Accretive Health, Inc.
Director Stock Option (right to buy)
A - Award 109,473 109,473 4.75 519,997 519,997
2013-11-19 3 AH Accretive Health, Inc.
No securities are beneficially owned
0
2013-10-31 2013-10-29 4 DELL DELL INC
Nonqualified Stock Options
D - Sale to Issuer -15,775 0 -100.00
2013-10-31 2013-10-29 4 DELL DELL INC
Nonqualified Stock Options
D - Sale to Issuer -7,539 0 -100.00
2013-10-31 2013-10-29 4 DELL DELL INC
Nonqualified Stock Options
D - Sale to Issuer -5,500 0 -100.00
2013-10-31 2013-10-29 4 DELL DELL INC
Nonqualified Stock Options
D - Sale to Issuer -7,492 0 -100.00
2013-10-31 2013-10-29 4 DELL DELL INC
Common Stock
D - Sale to Issuer -1,300 0 -100.00 13.75 -17,875
2013-10-31 2013-10-29 4 DELL DELL INC
Common Stock
D - Sale to Issuer -4,351 0 -100.00 13.75 -59,826
2013-10-31 2013-10-29 4 DELL DELL INC
Common Stock
D - Sale to Issuer -84,724 0 -100.00 13.75 -1,164,959
2013-08-16 2013-01-23 4 DELL DELL INC
Common Stock
P - Purchase 212 84,724 0.25 13.22 2,808 1,120,055
2013-08-16 2012-10-22 4 DELL DELL INC
Common Stock
P - Purchase 288 84,512 0.34 9.68 2,786 818,075
2013-07-18 2013-07-17 4 G Genpact LTD
Common Shares
A - Award 5,788 14,471 66.66
2013-07-18 2013-07-17 4 G Genpact LTD
Common Shares
A - Award 8,683 8,683
2012-07-17 2012-07-13 4 DELL DELL INC
Common Stock
A - Award 17,046 84,224 25.37
2006-12-18 2006-12-14 4 GTLT Global Telecom & Technology, Inc.
Common Stock
A - Award 16,129 16,129
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)